Neurotrophic artemin promotes motility and invasiveness of MIA PaCa-2 pancreatic cancer cells

9Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

Abstract

Objective: To analyze the capacity of neurotrophic artemin to promote the motility and invasiveness of MIA PaCa-2 pancreatic cancer cells. Methods: MIA PaCa-2 was cultured in vitro and studied using transwell chambers for motility and invasiveness on treatment with different concentrations of aArtemin or its receptor GFRa3 were also determined. Expression of matrix metalloproteinase-2 (MMP-2) and epithelial cadherin (E-cadherin) was quantified using RT-PCR and Western blotting. Results: MIA PaCa-2 pancreatic cancer cell motility and invasiveness was significantly increased with artemin and its receptor GFRa3 with dose dependence (P<0.01). MMP-2 production was also significantly increased (t = 6.35, t = 7.32), while E-cadherin was significantly lowered (t = 4.27, t = 5.61) (P <0.01). Conclusion: Artemin and its receptor GFRa3 can promote pancreatic cancer cell motility and invasiveness and contribute to aggressive behavior. The mechanism may be related to increased expression of MMP-2 molecule and down-regulation of E-cadherin expression.

Cite

CITATION STYLE

APA

Meng, L. X., Chi, Y. H., Wang, X. X., Ding, Z. J., Fei, L. C., Zhang, H., … Xue, Y. J. (2012). Neurotrophic artemin promotes motility and invasiveness of MIA PaCa-2 pancreatic cancer cells. Asian Pacific Journal of Cancer Prevention, 13(5), 1793–1797. https://doi.org/10.7314/APJCP.2012.13.5.1793

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free